Here are relevant reports on : oral-contraceptive-market
-
Pharmaceutical Drug Delivery Market By Administration Route (Oral, Injectable, Topical, Ocular, Nasal, Transmucosal & Implantable, Pulmonary, Transdermal Patch), Application (Cancer, Diabetes, Cardiovascular), Facility of Use - Global Forecast to 2031
The global pharmaceutical drug delivery market is projected to reach USD 2,922.82 billion by 2031, growing at a CAGR of 6.3% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Contrast Media Market By Type (lodinated Contrast Media), Form (Liquid, Powder), Modality (X-ray, MRI, Ultrasound), Route of Administration (Oral, Rectal), Indication (Cancer, Neurological, GI, Musculoskeletal Disorders) & Region - Global Forecast to 2031
The Contrast Media market, valued at USD 7.65 billion in 2025, stood at USD 8.20 billion in 2026 and is projected to advance at a resilient CAGR of 7.9% from 2026 to 2031, culminating in a forecasted valuation of USD 12.08 billion by the end of the period. Factors driving this growth include the increase in people with chronic conditions, like cardiovascular disease, cancer and neurological disorders, and, also, increase in the number of people getting diagnostic imaging tests on a global basis.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector, mRNA), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR, RSV), Route of Administration (IM, SC, Oral)-Global Forecast to 2030
The global vaccines market (excluding COVID-19 vaccines), valued at USD 49.59 billion in 2024, stood at USD 47.65 billion in 2025 and is projected to advance at a resilient CAGR of 7.3% from 2025 to 2030, culminating in a forecasted valuation of USD 67.91 billion by the end of the period.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
Veterinary Vaccines Market by Type (Porcine, Poultry, Livestock, Companion Animals), Technology (Live Attenuated, Inactivated, Toxoid), Route of Administration (Intramuscular, Subcutaneous, Oral), End User (Hospitals, Clinics) - Global Forecast to 2030
The global veterinary vaccines market, valued at USD10.94 billion in 2024, stood at USD11.63 billion in 2025 and is projected to advance at a resilient CAGR of 6.8% from 2025 to 2030, culminating in a forecasted valuation of USD16.15 billion by the end of the period. The continuous focus on developing novel and advanced vaccines, combined with the increasing application of these vaccines in emerging economies, is expected to drive market growth.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Veterinary Biologics Market by Product (Monoclonal Antibodies, Diagnostic Kits, Immunoglobulins & Antitoxins), RoA (Injectable, Oral), Application (Infectious Disease Prevention, Dermatology, Pain Management), Animal, End User - Global Forecast to 2030
The global veterinary biologics market, valued at US$2.61 billion in 2024, stood at US$2.72 billion in 2025 and is projected to advance at a resilient CAGR of 5.2% from 2024 to 2030, culminating in a forecasted valuation of US$3.51 billion by the end of the period. The market growth is fueled by increasing demand for effective animal therapeutics, rising populations of livestock and companion animals, and greater awareness of animal health and disease prevention.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Humectants Market by Type (Sugar Alcohol, Glycerol, Alpha Hydroxy Acid & Polysaccharides, Glycols), Application (Food & Beverages, Oral & Personal Care, Pharmaceuticals, Animal Feed), Source (Synthetic, Natural), and Region - Global Forecast to 2022
The humectants market is projected to reach USD 26.27 Billion by 2022, at a CAGR of 7.0% from 2017, in terms of value. In terms of volume, the market is projected to reach 14,741.6 KT by 2022, at a CAGR of 3.9% from 2017. Key players such as Cargill (U.S.), The Dow Chemical Company (U.S.), Archer Daniels Midland Company (U.S.), E. I. du Pont de Nemours and Company (U.S.), and Roquette Frères (France) have been profiled in the report. These leading players have adopted various strategies such as expansions & investments, mergers & acquisitions, and new product launches to explore new and untapped markets, expanding in local areas of emerging markets, and developing a new customer base for long-term client relationships. This has not only enabled the key players to expand their geographical reach, but has also reinforced their market position by gaining a larger share in terms of revenues and product portfolios.
- Published: July 2017
- Price: $ 4950
- TOC Available:
-
Animal Antibiotics and Antimicrobials Market by Product (Tetracycline, Penicillin, Sulfonamide, Macrolide, Cephalosporin, Lincosamide), Mode of Delivery (Premixes, Oral Solution, Injection), Animal (Food producing & Companion) & Region - Global Forecast to 2026
The global animal antibiotics market growth is primed to transition from $4.7 billion in 2021 to $5.6 billion by 2026, showcasing a strong CAGR of 3.6%. Market growth can largely be attributed to the rising demand for animal-derived food products, increasing incidence of zoonotic diseases, and the implementation of regulations to prevent the spread of animal diseases.
- Published: March 2021
- Price: $ 4950
- TOC Available:
-
North America Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR), Route of Administration (IM, SC, Oral) - Forecast to 2030
The North America vaccines market, valued at US$25.95 billion in 2024, stood at US$25.29 billion in 2025 and is projected to advance at a resilient CAGR of 7.1% from 2025 to 2030, culminating in a forecasted valuation of US$35.68 billion by the end of the period. The vaccines market is growing rapidly, driven by swift global vaccine development and commercialization, higher rates of infectious diseases necessitating preventive vaccines, expanded immunization initiatives, innovations in vaccine technology, and increased government funding and investments for novel vaccines against diverse diseases.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Feed Anticoccidials Market by Livestock (Poultry, Ruminant, Swine), Type (Monensin, Salinomycin, Narasin, Diclazuril), Form (Dry, Liquid), Source (Chemical, Natural), Mode of Consumption (Oral, Injection) And Region - Global Forecast to 2025
The feed anticoccidials market is estimated to account for USD 331 million in 2019 and is projected to reach USD 429 million by 2025, at a CAGR of 4.4% during the forecast period. Elanco Animal Health (US), Huvepharma (Bulgaria), Phibro Animal Health (US), Ceva Animal Health (France), Zoetis (US), Impextraco (Belgium), Kemin Industries (US), Merck Animal Health (US), Virbac SA (France), Zydus Animal Health (India), Bioproperties Pty. Ltd. (Australia), and Qilu Animal Health Products Co. Ltd. (China).
- Published: July 2019
- Price: $ 4950
- TOC Available:
-
Asia Pacific Animal Parasiticides Market by Type [Ectoparasiticides (Pour-ons & Spot-ons, Dips), Endoparasiticides (Oral Liquids, Injectables, Feed Additives), Endectocides], Animal Type (Companion Animals, Livestock), End User - Forecast to 2031
The Asia Pacific animal parasiticides market, valued at USD 2.12 billion in 2025, stood at USD 2.26 billion in 2026 and is projected to advance at a resilient CAGR of 7.2% from 2026 to 2031, culminating in a forecasted valuation of USD 3.20 billion by the end of the period. The Asia Pacific animal parasiticides market is growing due to rising levels of parasite infestation among livestock and companion animals, expanding animal populations, and greater focus on preventive animal healthcare.
- Published: May 2026
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
